amlodipine has been researched along with Glomerulonephritis in 9 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we conducted an open-label and randomized trial to compare the effects of benidipine with those of amlodipine on blood pressure (BP), albuminuria and aldosterone concentration in hypertensive patients with mild-to-moderate stage chronic kidney disease (CKD)." | 9.15 | Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. ( Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M, 2011) |
| " The present study compared the chronic effects of efonidipine and amlodipine on proteinuria in patients with chronic glomerulonephritis." | 9.12 | Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. ( Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M, 2007) |
| "Hydralazine is a medication that has been used to manage hypertension and heart failure." | 7.80 | Hydralazine associated pauci-immune glomerulonephritis. ( Baiswar, S; Suneja, M; Vogelgesang, SA, 2014) |
| " In this study, we conducted an open-label and randomized trial to compare the effects of benidipine with those of amlodipine on blood pressure (BP), albuminuria and aldosterone concentration in hypertensive patients with mild-to-moderate stage chronic kidney disease (CKD)." | 5.15 | Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. ( Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M, 2011) |
| " The present study compared the chronic effects of efonidipine and amlodipine on proteinuria in patients with chronic glomerulonephritis." | 5.12 | Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. ( Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M, 2007) |
| " Our aim was to prospectively compare the effects of amlodipine and ACEI (enalapril) on renal function in hypertensive patients with renal impairment due to chronic glomerulonephritis and essential hypertension." | 5.09 | Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study. ( Hayashi, K; Kumagai, H; Kumamaru, H; Saruta, T, 2000) |
| "Hydralazine is a medication that has been used to manage hypertension and heart failure." | 3.80 | Hydralazine associated pauci-immune glomerulonephritis. ( Baiswar, S; Suneja, M; Vogelgesang, SA, 2014) |
| "The results of this study suggested that the L/N-type CCB, cilnidipine, had additive antihypertensive and proteinuria-lowering effects when administered in combination with an ARB, even in type-1 diabetic rats, and that the L-type CCB, amlodipine, did not." | 3.79 | Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats. ( Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T, 2013) |
| "Our data show that the effects of losartan and amlodipine on the absolute mean reduction of blood pressure and proteinuria in non-diabetic nephropathy patients are similar between the different ACE or AGT genotypes." | 3.73 | [Pharmacogenetics of angiotensin system in non diabetic nephropathy]. ( Alvarez, V; Arias, M; Campistol, JM; Coto, E; Fernández Andrade, C; Galcerán, JM; Luño, J; Marín, R; Poveda, R; Praga, M; Rivera, F; Vallés, M, 2005) |
| "Poststreptococcal glomerulonephritis is the best known example." | 1.48 | Acute infection-related glomerulonephritis with disseminated gonococcal infection in a 13-year-old girl. ( Chandra, M; D'Agati, V; Krilov, LR; Noor, A, 2018) |
| "Patients with immunoglobulin A nephropathy administered ACE inhibitors showed significantly lower renal TGF-beta1 gene expression than patients not administered these medications (mean ratios of TGF-beta1/beta-actin, 4." | 1.31 | ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. ( Kim, D; Kim, HS; Kim, SJ; Ma, KA; Shin, GT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noor, A | 1 |
| Krilov, LR | 1 |
| D'Agati, V | 1 |
| Chandra, M | 1 |
| Suneja, M | 1 |
| Baiswar, S | 1 |
| Vogelgesang, SA | 1 |
| Aritomi, S | 2 |
| Koganei, H | 1 |
| Wagatsuma, H | 1 |
| Mitsui, A | 1 |
| Ogawa, T | 2 |
| Nitta, K | 2 |
| Konda, T | 2 |
| Abe, M | 1 |
| Okada, K | 1 |
| Maruyama, N | 1 |
| Matsumoto, S | 1 |
| Maruyama, T | 1 |
| Fujita, T | 1 |
| Matsumoto, K | 1 |
| Soma, M | 1 |
| Niinuma, K | 1 |
| Coto, E | 1 |
| Marín, R | 1 |
| Alvarez, V | 1 |
| Praga, M | 1 |
| Fernández Andrade, C | 1 |
| Arias, M | 1 |
| Poveda, R | 1 |
| Vallés, M | 1 |
| Galcerán, JM | 1 |
| Luño, J | 1 |
| Rivera, F | 1 |
| Campistol, JM | 1 |
| Ishimitsu, T | 1 |
| Kameda, T | 1 |
| Akashiba, A | 1 |
| Takahashi, T | 1 |
| Ohta, S | 1 |
| Yoshii, M | 1 |
| Minami, J | 1 |
| Ono, H | 1 |
| Numabe, A | 1 |
| Matsuoka, H | 1 |
| Kumagai, H | 1 |
| Hayashi, K | 1 |
| Kumamaru, H | 1 |
| Saruta, T | 1 |
| Shin, GT | 1 |
| Kim, SJ | 1 |
| Ma, KA | 1 |
| Kim, HS | 1 |
| Kim, D | 1 |
3 trials available for amlodipine and Glomerulonephritis
| Article | Year |
|---|---|
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calciu | 2011 |
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L- | 2007 |
Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Chr | 2000 |
6 other studies available for amlodipine and Glomerulonephritis
| Article | Year |
|---|---|
Acute infection-related glomerulonephritis with disseminated gonococcal infection in a 13-year-old girl.
Topics: Acute Disease; Adolescent; Amlodipine; Anti-Bacterial Agents; Antihypertensive Agents; Biopsy; Ceftr | 2018 |
Hydralazine associated pauci-immune glomerulonephritis.
Topics: Aged; Aged, 80 and over; Amlodipine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Ant | 2014 |
The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; | 2010 |
Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; B | 2013 |
[Pharmacogenetics of angiotensin system in non diabetic nephropathy].
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel | 2005 |
ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Block | 2000 |